Immuneering Corporation (IMRX)
NASDAQ·Healthcare·Biotechnology
$4.27
-5.80%
Mkt Cap $155.01M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$14.33
Range $12.00 – $17.00
Implied Upside
+235.6%
Consensus $14.33 vs current $4.27
NASDAQ·Healthcare·Biotechnology
$4.27
-5.80%
Mkt Cap $155.01M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$14.33
Range $12.00 – $17.00
+235.6%
Consensus $14.33 vs current $4.27